Filing Details
- Accession Number:
- 0000899243-21-048230
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-14 20:48:34
- Reporting Period:
- 2021-12-10
- Accepted Time:
- 2021-12-14 20:48:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1835579 | Ikena Oncology Inc. | IKNA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1895321 | Michelle Xiaoyan Zhang | C/O Ikena Oncology, Inc. 645 Summer Street, Suite 101 Boston MA 02210 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-10 | 1,000 | $2.15 | 45,475 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-12-10 | 1,000 | $14.76 | 44,475 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-12-10 | 1,000 | $0.00 | 1,000 | $2.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,473 | 2028-12-17 | No | 4 | M | Direct |
Footnotes
- 25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.